← 產業報告目錄
Helicobacter Pylori Infection Treatment Industry Research Report 2026
出版商 APO Research產業別 Software & IT Services出版日期 2026-07-04頁數 119報告編號 APO-a8b9b70d1c
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global Helicobacter Pylori Infection Treatment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Helicobacter Pylori Infection Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Helicobacter Pylori Infection Treatment market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Helicobacter Pylori Infection Treatment market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Helicobacter Pylori Infection Treatment include Cumberland Pharmaceuticals, Eisai Co., Bio-Rad Laboratories, F. Hoffmann-La Roche, Alpha Laboratories, Biohit, Phathom Pharmaceuticals, Redhill Biopharma and Takeda Pharmaceuticals and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Helicobacter Pylori Infection Treatment market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Helicobacter Pylori Infection Treatment.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Helicobacter Pylori Infection Treatment Market by Company
Cumberland Pharmaceuticals
Eisai Co.
Bio-Rad Laboratories
F. Hoffmann-La Roche
Alpha Laboratories
Biohit
Phathom Pharmaceuticals
Redhill Biopharma
Takeda Pharmaceuticals
AbbVie
Helicobacter Pylori Infection Treatment Segment by Type
Bismuth-quadruple Therapy
Concomitant Therapy
Levofloxacin Triple Therapy
Bismuth Therapy
High-dose Dual Therapy
Helicobacter Pylori Infection Treatment Segment by Application
Hospitals
Diagnostics Laboratories
Clinics
Helicobacter Pylori Infection Treatment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Helicobacter Pylori Infection Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Helicobacter Pylori Infection Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Helicobacter Pylori Infection Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Helicobacter Pylori Infection Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Helicobacter Pylori Infection Treatment by Type
2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
2.2.2 Bismuth-quadruple Therapy
2.2.3 Concomitant Therapy
2.2.4 Levofloxacin Triple Therapy
2.2.5 Bismuth Therapy
2.2.6 High-dose Dual Therapy
2.3 Helicobacter Pylori Infection Treatment by Application
2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.3.2 Hospitals
2.3.3 Diagnostics Laboratories
2.3.4 Clinics
2.4 Assumptions and Limitations
3 Helicobacter Pylori Infection Treatment Breakdown Data by Type
3.1 Global Helicobacter Pylori Infection Treatment Historic Market Size by Type (2021-2026)
3.2 Global Helicobacter Pylori Infection Treatment Forecasted Market Size by Type (2027-2032)
4 Helicobacter Pylori Infection Treatment Breakdown Data by Application
4.1 Global Helicobacter Pylori Infection Treatment Historic Market Size by Application (2021-2026)
4.2 Global Helicobacter Pylori Infection Treatment Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
5.1 Global Helicobacter Pylori Infection Treatment Market Perspective (2021-2032)
5.2 Global Helicobacter Pylori Infection Treatment Growth Trends by Region
5.2.1 Global Helicobacter Pylori Infection Treatment Market Size by Region: 2021 VS 2025 VS 2032
5.2.2 Helicobacter Pylori Infection Treatment Historic Market Size by Region (2021-2026)
5.2.3 Helicobacter Pylori Infection Treatment Forecasted Market Size by Region (2027-2032)
5.3 Helicobacter Pylori Infection Treatment Market Dynamics
5.3.1 Helicobacter Pylori Infection Treatment Industry Trends
5.3.2 Helicobacter Pylori Infection Treatment Market Drivers
5.3.3 Helicobacter Pylori Infection Treatment Market Challenges
5.3.4 Helicobacter Pylori Infection Treatment Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Helicobacter Pylori Infection Treatment Players by Revenue
6.1.1 Global Top Helicobacter Pylori Infection Treatment Players by Revenue (2021-2026)
6.1.2 Global Helicobacter Pylori Infection Treatment Revenue Market Share by Players (2021-2026)
6.2 Global Helicobacter Pylori Infection Treatment Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Helicobacter Pylori Infection Treatment Head Office and Area Served
6.4 Global Helicobacter Pylori Infection Treatment Players, Product Type & Application
6.5 Global Helicobacter Pylori Infection Treatment Manufacturers Established Date
6.6 Global Helicobacter Pylori Infection Treatment Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Helicobacter Pylori Infection Treatment Market Size (2021-2032)
7.2 North America Helicobacter Pylori Infection Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
7.3 North America Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026)
7.4 North America Helicobacter Pylori Infection Treatment Market Size by Country (2027-2032)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Helicobacter Pylori Infection Treatment Market Size (2021-2032)
8.2 Europe Helicobacter Pylori Infection Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
8.3 Europe Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026)
8.4 Europe Helicobacter Pylori Infection Treatment Market Size by Country (2027-2032)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Helicobacter Pylori Infection Treatment Market Size (2021-2032)
9.2 Asia-Pacific Helicobacter Pylori Infection Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
9.3 Asia-Pacific Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026)
9.4 Asia-Pacific Helicobacter Pylori Infection Treatment Market Size by Country (2027-2032)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Helicobacter Pylori Infection Treatment Market Size (2021-2032)
10.2 South America Helicobacter Pylori Infection Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
10.3 South America Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026)
10.4 South America Helicobacter Pylori Infection Treatment Market Size by Country (2027-2032)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Helicobacter Pylori Infection Treatment Market Size (2021-2032)
11.2 Middle East & Africa Helicobacter Pylori Infection Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
11.3 Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026)
11.4 Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Country (2027-2032)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Cumberland Pharmaceuticals
12.1.1 Cumberland Pharmaceuticals Company Information
12.1.2 Cumberland Pharmaceuticals Business Overview
12.1.3 Cumberland Pharmaceuticals Revenue in Helicobacter Pylori Infection Treatment Business (2021-2026)
12.1.4 Cumberland Pharmaceuticals Helicobacter Pylori Infection Treatment Product Portfolio
12.1.5 Cumberland Pharmaceuticals Recent Developments
12.2 Eisai Co.
12.2.1 Eisai Co. Company Information
12.2.2 Eisai Co. Business Overview
12.2.3 Eisai Co. Revenue in Helicobacter Pylori Infection Treatment Business (2021-2026)
12.2.4 Eisai Co. Helicobacter Pylori Infection Treatment Product Portfolio
12.2.5 Eisai Co. Recent Developments
12.3 Bio-Rad Laboratories
12.3.1 Bio-Rad Laboratories Company Information
12.3.2 Bio-Rad Laboratories Business Overview
12.3.3 Bio-Rad Laboratories Revenue in Helicobacter Pylori Infection Treatment Business (2021-2026)
12.3.4 Bio-Rad Laboratories Helicobacter Pylori Infection Treatment Product Portfolio
12.3.5 Bio-Rad Laboratories Recent Developments
12.4 F. Hoffmann-La Roche
12.4.1 F. Hoffmann-La Roche Company Information
12.4.2 F. Hoffmann-La Roche Business Overview
12.4.3 F. Hoffmann-La Roche Revenue in Helicobacter Pylori Infection Treatment Business (2021-2026)
12.4.4 F. Hoffmann-La Roche Helicobacter Pylori Infection Treatment Product Portfolio
12.4.5 F. Hoffmann-La Roche Recent Developments
12.5 Alpha Laboratories
12.5.1 Alpha Laboratories Company Information
12.5.2 Alpha Laboratories Business Overview
12.5.3 Alpha Laboratories Revenue in Helicobacter Pylori Infection Treatment Business (2021-2026)
12.5.4 Alpha Laboratories Helicobacter Pylori Infection Treatment Product Portfolio
12.5.5 Alpha Laboratories Recent Developments
12.6 Biohit
12.6.1 Biohit Company Information
12.6.2 Biohit Business Overview
12.6.3 Biohit Revenue in Helicobacter Pylori Infection Treatment Business (2021-2026)
12.6.4 Biohit Helicobacter Pylori Infection Treatment Product Portfolio
12.6.5 Biohit Recent Developments
12.7 Phathom Pharmaceuticals
12.7.1 Phathom Pharmaceuticals Company Information
12.7.2 Phathom Pharmaceuticals Business Overview
12.7.3 Phathom Pharmaceuticals Revenue in Helicobacter Pylori Infection Treatment Business (2021-2026)
12.7.4 Phathom Pharmaceuticals Helicobacter Pylori Infection Treatment Product Portfolio
12.7.5 Phathom Pharmaceuticals Recent Developments
12.8 Redhill Biopharma
12.8.1 Redhill Biopharma Company Information
12.8.2 Redhill Biopharma Business Overview
12.8.3 Redhill Biopharma Revenue in Helicobacter Pylori Infection Treatment Business (2021-2026)
12.8.4 Redhill Biopharma Helicobacter Pylori Infection Treatment Product Portfolio
12.8.5 Redhill Biopharma Recent Developments
12.9 Takeda Pharmaceuticals
12.9.1 Takeda Pharmaceuticals Company Information
12.9.2 Takeda Pharmaceuticals Business Overview
12.9.3 Takeda Pharmaceuticals Revenue in Helicobacter Pylori Infection Treatment Business (2021-2026)
12.9.4 Takeda Pharmaceuticals Helicobacter Pylori Infection Treatment Product Portfolio
12.9.5 Takeda Pharmaceuticals Recent Developments
12.10 AbbVie
12.10.1 AbbVie Company Information
12.10.2 AbbVie Business Overview
12.10.3 AbbVie Revenue in Helicobacter Pylori Infection Treatment Business (2021-2026)
12.10.4 AbbVie Helicobacter Pylori Infection Treatment Product Portfolio
12.10.5 AbbVie Recent Developments
13 Report Conclusion
14 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Helicobacter Pylori Infection Treatment Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global Helicobacter Pylori Infection Treatment Revenue Market Share by Type (2021-2026)
Table 7. Global Helicobacter Pylori Infection Treatment Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global Helicobacter Pylori Infection Treatment Revenue Market Share by Type (2027-2032)
Table 9. Global Helicobacter Pylori Infection Treatment Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global Helicobacter Pylori Infection Treatment Revenue Market Share by Application (2021-2026)
Table 11. Global Helicobacter Pylori Infection Treatment Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global Helicobacter Pylori Infection Treatment Revenue Market Share by Application (2027-2032)
Table 13. Global Helicobacter Pylori Infection Treatment Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global Helicobacter Pylori Infection Treatment Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global Helicobacter Pylori Infection Treatment Market Share by Region (2021-2026)
Table 16. Global Helicobacter Pylori Infection Treatment Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global Helicobacter Pylori Infection Treatment Market Share by Region (2027-2032)
Table 18. Helicobacter Pylori Infection Treatment Industry Trends
Table 19. Helicobacter Pylori Infection Treatment Industry Drivers
Table 20. Helicobacter Pylori Infection Treatment Industry Opportunities and Challenges
Table 21. Helicobacter Pylori Infection Treatment Market Restraints
Table 22. Global Top Helicobacter Pylori Infection Treatment Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global Helicobacter Pylori Infection Treatment Revenue Market Share by Players (2021-2026)
Table 24. Global Helicobacter Pylori Infection Treatment Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of Helicobacter Pylori Infection Treatment, Headquarters and Area Served
Table 26. Global Helicobacter Pylori Infection Treatment Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Helicobacter Pylori Infection Treatment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America Helicobacter Pylori Infection Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America Helicobacter Pylori Infection Treatment Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe Helicobacter Pylori Infection Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe Helicobacter Pylori Infection Treatment Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific Helicobacter Pylori Infection Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific Helicobacter Pylori Infection Treatment Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific Helicobacter Pylori Infection Treatment Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America Helicobacter Pylori Infection Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America Helicobacter Pylori Infection Treatment Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa Helicobacter Pylori Infection Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Country (2027-2032) & (US$ Million)
Table 45. Cumberland Pharmaceuticals Company Information
Table 46. Cumberland Pharmaceuticals Business Overview
Table 47. Cumberland Pharmaceuticals Revenue in Helicobacter Pylori Infection Treatment Business (2021-2026) & (US$ Million)
Table 48. Cumberland Pharmaceuticals Helicobacter Pylori Infection Treatment Product Portfolio
Table 49. Cumberland Pharmaceuticals Recent Developments
Table 50. Eisai Co. Company Information
Table 51. Eisai Co. Business Overview
Table 52. Eisai Co. Revenue in Helicobacter Pylori Infection Treatment Business (2021-2026) & (US$ Million)
Table 53. Eisai Co. Helicobacter Pylori Infection Treatment Product Portfolio
Table 54. Eisai Co. Recent Developments
Table 55. Bio-Rad Laboratories Company Information
Table 56. Bio-Rad Laboratories Business Overview
Table 57. Bio-Rad Laboratories Revenue in Helicobacter Pylori Infection Treatment Business (2021-2026) & (US$ Million)
Table 58. Bio-Rad Laboratories Helicobacter Pylori Infection Treatment Product Portfolio
Table 59. Bio-Rad Laboratories Recent Developments
Table 60. F. Hoffmann-La Roche Company Information
Table 61. F. Hoffmann-La Roche Business Overview
Table 62. F. Hoffmann-La Roche Revenue in Helicobacter Pylori Infection Treatment Business (2021-2026) & (US$ Million)
Table 63. F. Hoffmann-La Roche Helicobacter Pylori Infection Treatment Product Portfolio
Table 64. F. Hoffmann-La Roche Recent Developments
Table 65. Alpha Laboratories Company Information
Table 66. Alpha Laboratories Business Overview
Table 67. Alpha Laboratories Revenue in Helicobacter Pylori Infection Treatment Business (2021-2026) & (US$ Million)
Table 68. Alpha Laboratories Helicobacter Pylori Infection Treatment Product Portfolio
Table 69. Alpha Laboratories Recent Developments
Table 70. Biohit Company Information
Table 71. Biohit Business Overview
Table 72. Biohit Revenue in Helicobacter Pylori Infection Treatment Business (2021-2026) & (US$ Million)
Table 73. Biohit Helicobacter Pylori Infection Treatment Product Portfolio
Table 74. Biohit Recent Developments
Table 75. Phathom Pharmaceuticals Company Information
Table 76. Phathom Pharmaceuticals Business Overview
Table 77. Phathom Pharmaceuticals Revenue in Helicobacter Pylori Infection Treatment Business (2021-2026) & (US$ Million)
Table 78. Phathom Pharmaceuticals Helicobacter Pylori Infection Treatment Product Portfolio
Table 79. Phathom Pharmaceuticals Recent Developments
Table 80. Redhill Biopharma Company Information
Table 81. Redhill Biopharma Business Overview
Table 82. Redhill Biopharma Revenue in Helicobacter Pylori Infection Treatment Business (2021-2026) & (US$ Million)
Table 83. Redhill Biopharma Helicobacter Pylori Infection Treatment Product Portfolio
Table 84. Redhill Biopharma Recent Developments
Table 85. Takeda Pharmaceuticals Company Information
Table 86. Takeda Pharmaceuticals Business Overview
Table 87. Takeda Pharmaceuticals Revenue in Helicobacter Pylori Infection Treatment Business (2021-2026) & (US$ Million)
Table 88. Takeda Pharmaceuticals Helicobacter Pylori Infection Treatment Product Portfolio
Table 89. Takeda Pharmaceuticals Recent Developments
Table 90. AbbVie Company Information
Table 91. AbbVie Business Overview
Table 92. AbbVie Revenue in Helicobacter Pylori Infection Treatment Business (2021-2026) & (US$ Million)
Table 93. AbbVie Helicobacter Pylori Infection Treatment Product Portfolio
Table 94. AbbVie Recent Developments
Table 95. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Helicobacter Pylori Infection Treatment Product Image
Figure 5. Global Helicobacter Pylori Infection Treatment Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global Helicobacter Pylori Infection Treatment Market Share by Type: 2025 VS 2032
Figure 7. Bismuth-quadruple Therapy Product
Figure 8. Concomitant Therapy Product
Figure 9. Levofloxacin Triple Therapy Product
Figure 10. Bismuth Therapy Product
Figure 11. High-dose Dual Therapy Product
Figure 12. Global Helicobacter Pylori Infection Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 13. Global Helicobacter Pylori Infection Treatment Market Share by Application: 2025 VS 2032
Figure 14. Hospitals Product
Figure 15. Diagnostics Laboratories Product
Figure 16. Clinics Product
Figure 17. Global Helicobacter Pylori Infection Treatment Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 18. Global Helicobacter Pylori Infection Treatment Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 19. Global Helicobacter Pylori Infection Treatment Market Share by Region: 2025 VS 2032
Figure 20. Global Helicobacter Pylori Infection Treatment Market Share by Players in 2025
Figure 21. Global Helicobacter Pylori Infection Treatment Manufacturers Established Date
Figure 22. Global Top 5 and 10 Helicobacter Pylori Infection Treatment Players Market Share by Revenue in 2025
Figure 23. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 24. North America Helicobacter Pylori Infection Treatment Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 25. North America Helicobacter Pylori Infection Treatment Market Share by Country (2021-2032)
Figure 26. United States Helicobacter Pylori Infection Treatment Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 27. Canada Helicobacter Pylori Infection Treatment Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 28. Mexico Helicobacter Pylori Infection Treatment Market Share by Country (2021-2032)
Figure 29. Europe Helicobacter Pylori Infection Treatment Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 30. Europe Helicobacter Pylori Infection Treatment Market Share by Country (2021-2032)
Figure 31. Germany Helicobacter Pylori Infection Treatment Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 32. France Helicobacter Pylori Infection Treatment Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. U.K. Helicobacter Pylori Infection Treatment Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. Italy Helicobacter Pylori Infection Treatment Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Spain Helicobacter Pylori Infection Treatment Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Russia Helicobacter Pylori Infection Treatment Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Netherlands Helicobacter Pylori Infection Treatment Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 38. Nordic Countries Helicobacter Pylori Infection Treatment Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 39. Asia-Pacific Helicobacter Pylori Infection Treatment Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 40. Asia-Pacific Helicobacter Pylori Infection Treatment Market Share by Country (2021-2032)
Figure 41. China Helicobacter Pylori Infection Treatment Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 42. Japan Helicobacter Pylori Infection Treatment Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 43. South Korea Helicobacter Pylori Infection Treatment Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 44. India Helicobacter Pylori Infection Treatment Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 45. India Helicobacter Pylori Infection Treatment Market Share by Country (2021-2032)
Figure 46. Australia Helicobacter Pylori Infection Treatment Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 47. China Taiwan Helicobacter Pylori Infection Treatment Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 48. Southeast Asia Helicobacter Pylori Infection Treatment Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 49. South America Helicobacter Pylori Infection Treatment Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 50. South America Helicobacter Pylori Infection Treatment Market Share by Country (2021-2032)
Figure 51. Brazil Helicobacter Pylori Infection Treatment Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. Argentina Helicobacter Pylori Infection Treatment Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. Chile Helicobacter Pylori Infection Treatment Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 54. Colombia Helicobacter Pylori Infection Treatment Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 55. Peru Helicobacter Pylori Infection Treatment Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 56. Cumberland Pharmaceuticals Revenue Growth Rate in Helicobacter Pylori Infection Treatment Business (2021-2026)
Figure 57. Eisai Co. Revenue Growth Rate in Helicobacter Pylori Infection Treatment Business (2021-2026)
Figure 58. Bio-Rad Laboratories Revenue Growth Rate in Helicobacter Pylori Infection Treatment Business (2021-2026)
Figure 59. F. Hoffmann-La Roche Revenue Growth Rate in Helicobacter Pylori Infection Treatment Business (2021-2026)
Figure 60. Alpha Laboratories Revenue Growth Rate in Helicobacter Pylori Infection Treatment Business (2021-2026)
Figure 61. Biohit Revenue Growth Rate in Helicobacter Pylori Infection Treatment Business (2021-2026)
Figure 62. Phathom Pharmaceuticals Revenue Growth Rate in Helicobacter Pylori Infection Treatment Business (2021-2026)
Figure 63. Redhill Biopharma Revenue Growth Rate in Helicobacter Pylori Infection Treatment Business (2021-2026)
Figure 64. Takeda Pharmaceuticals Revenue Growth Rate in Helicobacter Pylori Infection Treatment Business (2021-2026)
Figure 65. AbbVie Revenue Growth Rate in Helicobacter Pylori Infection Treatment Business (2021-2026)
提及公司
Cumberland PharmaceuticalsEisai Co.Bio-Rad LaboratoriesF. Hoffmann-La RocheAlpha LaboratoriesBiohitPhathom PharmaceuticalsRedhill BiopharmaTakeda PharmaceuticalsAbbVie
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們